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Structure Activity Relationships Among
Dithiocarbamate Antidotes for Acute
Cadmium Chloride Intoxication
by Shirley G. Jones* and Mark M. Jones*
Eight sodium dithiocarbamates (NaS2CNRlR2) have been examined as antidotes for
acute cadmium intoxication. While all of them possess an ability to increase survival
when given to mice 2 hr after a lethal (>99%7) intraperitoneal injection of 10 mg/kg of
CdCl2*2.5H20, their effects on the organ distribution of cadmium vary considerably. It
has been possible to show that the accumulation ofcadmium in the brain and kidney as
well as the survival rates can be correlated with a numerical measure of the polarity of
the groups R, and R2. Each factor has a different dependence on the polarity, but it is
possible to construct a composite factor for antidotal efficacy which incorporates sur-
vival rate, brain cadmium levels and kidney cadmium levels. The factor constructed here
exhibits an optimal value approximately in the middle of the polarity range studied.
Compounds which have R, = -CH2CH1OH and R2 = -CH2CH20H, or -CH3 or -C2H5
appear to be the most effective antidotes ofthe compounds examined.
Introduction
The discovery in 1981 by Gale and his co-
workers (1) that sodium diethyldithiocarbamate
was an effective antidote for acute cadmium in-
toxication, even when its administration was de-
layed until as much as 5 hr after the administra-
tion of a lethal (>99%) dose ofcadmium chloride,
represented a new departure in the search for
chelate antidotes for cadmium intoxication. This
finding has been confirmed and extended to a
number of structurally related dithiocarbamates
(2-4) in the search for compounds providing a
greater degree of control over the redistribution
of cadmium subsequent to the administration of
the antidote. One major problem encountered
with the use ofsodium diethyldithiocarbamate as
an antidote for cadmium intoxication is its tend-
ency to increase the cadmium content ofthe brain
(2,3,5). This is presumably related to the ability of
diethyldithiocarbamate to form lipid-soluble com-
plexes with cadmium (5). If this could be con-
trolled by structural modifications, the resulting
compounds should be more satisfactory antidotes
for cadmium intoxication. We have attempted to
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put this and other aspects ofthe behavior ofthese
antidotes on a quantitative basis. For this pur-
pose we have carried out a structure-activity
analysis on these compounds, using structural
parametersprovidedby the studies ofHansch and
Leo (6) to characterize the relative polarity ofthe
various dithiocarbamates studied. In the current
work we have used only the sodium salts ofthese
compounds, rather than the more readily crystal-
lized ammonium salts used in our earlier study
(3). This avoidsthe problems which arise from the
limited ability of the cadmium-damaged kidney
to handle ammonium salts. The goal of the cur-
rent study was to search for relationships which
existed between the structural parameters char-
acteristic ofthe compounds and various measures
ofthe antidotal activity which they exhibited. It
was believed that this would allow a more ra-
tional selection ofone or two ofthe compounds for
more detailed examination and furnish a guide in
the selection ofnew compounds for synthesis.
Methods
The methods used in the animal studies were
patterned afterthose ofGale et al. (1), except that
the animals were sacrificed 2 weeks ratherthan 4
weeks after the administration of the cadmium.JONES AND JONES
Male, ICR mice, weighing 30 + 4 g, obtained
from Harlan Industries, Indianapolis, Indiana,
were acclimated for 1 week before experimental
use. They were allowed food and water ad libi-
tum. A lethal (>99%) dose of CdCl2 2.5H2O was
given IP at a level of 10 mg/kg. Two hours later,
each animal was given a single IP injection ofthe
dithiocarbamate at a level of2.2 mmole/kg, with
an injectate volume of 0.1 or 0.2 mL, depending
on solubility. The pH was controlled for antidotes
with a high pHby adding a small chunk ofdry ice
to the solution to bring the pH down close to 7.
Sodium iminodiacetic acid dithiocarbamate was
given as a 1:1 Ca2+ salt to prevent tetany. After 2
weeks ofobservation the animals were sacrificed
by cervical dislocation and the cadmium content
determined on samples ofbrain, kidney and liver,
which had been digested in nitric acid, using
flame atomic absorption spectrophotometry.
The dithiocarbamates used in this study,were
prepared by using literature methods (9,10) and
were analyzed to contain 98.5% or better of the
indicated sodium dithiocarbamate. Only sodium
salts were used as these were found to produce
fewer complications and a reduced mortality in
comparison with the more readily crystallizable
ammonium salts.
Results
The results obtained with the eight compounds
selected arepresented inTable 1, which also gives
the structure ofeach ofthe compounds used. The
mice administered the dithiocarbamate antidotes
which were less effective in removing cadmium
from the animal, sodium sarcosine dithiocarba-
mate (IV), sodium iminodiacetic acid dithiocarba-
mate (VI), sodium ethyl(hydroxyethyl)di-
thiocarbamate (VII) and sodium propyl(hydrox-
yethyl)dithiocarbamate (VIII) showed a tendency
to have darkened, swollen livers, one kidney em-
bedded in the liver, and adhesions of liver or
intestine to the peritoneum. The better antidotes,
sodium diethyldithiocarbamate (I), sodium di-
methyldithiocarbamate (II), sodium methyl(hy-
droxyethyl)dithiocarbamate (V) and sodium di-
(hydroxyethyl)dithiocarbamate (III) produced
fewer ofthese gross abnormalities.
Cadmium was found to be present in the brain
of mice given sodium diethyldithiocarbamate (I)
and sodium dimethyldithiocarbamate (II) at lev-
els of2.6 and 2.3 ppm, respectively.
The effect of increased time intervals between
the administration of sodium di(hydroxyethyl)
dithiocarbamate (I) andthatofthe cadmium chlo-
ride is shown in Table 2.
Discussion
The data presented in Table 1 show that the
differences in the behavior of these dithiocarba-
mates is considerable. The variation in the
amounts of cadmium remaining in the kidney
and the brain is quite striking. The data on the
Table 1. Results ofstructure-activity studies.
Dose, Liver Kidney Brain
Compound mmole/kg Survival Cd, ppm Cd, ppm Cd, ppm
I H3C CH3
H2C \ CH2
C =s
S -, Na+
II H3C
_ CH3
N
C =S
S -, Na+
III HOCH2 CH2OH
C =S
S -, Na+
2.2
2.2
2.2
8/8 27.7 ± 6.0
8/8 16.9 ± 3.0
8/8 18.1 ± 7.4
20.6 ± 6.5
20.4 ± 9.5
2.6 + 1.6
2.3 + 0.5
14.2 + 5.7 0
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Table 1. Results of structure-activity studies (Continued).
Dose, Liver Kidney Brain
Compound mmole/kg Survival Cd, ppm Cd, ppm Cd, ppm
IV H3C-._ \ CH2-COOH
N
C =S
S -, Na+
CH20H
V H3C I-,"CH2 N
C =s
S -,Na+
VI HOOC COOH
H2C - CH2
N
C =s
S -,Na+
VII H3C CH2OH
H2C = CH2
N
C =S
S -, Na+
VIII H3C
H2C CH20H
H2C CH2
C =s
S -,Na+
2.2 8/8
2.2
2.2
2.2
2.2
26.6 ± 9.2
8/8 26.6 ± 4.7
7/8 25.3 ± 7.8
8/8 24.4 ± 2.2
8/8 25.1 ± 2.1
Table 2. Effect oftime interval on efficiency ofsodium di(hydroxyethyl) dithiocarbamate.a
Time interval
CdCl2 after Antidote
2.5 H20 cadmium, dosage, Survival Liver Kidney Brain
(IP), mg/kg min mmole/kg rateb Cd, ppm Cd, ppm Cd, ppm
10 20 min 2.2 8/8 12.0 ± 7.5 6.9 ± 6.2 -0-
10 120 2.2 8/8 18.1 ± 7.4 14.2 ± 5.7 -0-
10 480 2.2 4/8 30.8 ± 6.7 10.5 ± 6.7 -0-
aOrgan cadmium contents were determined at the end of2 weeks.
bAll cadmium-only control mice died within the first week. i
29.0 ± 12.4 0
18.3 ± 5.9 0
25.0 + 12.6 0
13.9 ± 5.8 0
26.8 ± 5.1 0
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diisopropyl derivative, available fromthestudy of
Gale and his co-workers (4), allow an extrapola-
tion ofourdata tocompounds in which the substi-
tuents on the nitrogen atom are longer organic
chains. The data in Table 1 suggest that the
changes in the relative hydrophobic/hydrophilic
character of the groups attached to the nitrogen
atom may be important in governing the trends
observed. In order to obtain a quantitative esti-
mate of the relative hydrophobicity of the R
groups in each compound, the sum ofthe X factors
ofthe Rgroups, asdeterminedbyHansch andLeo
(6), was used. These i factors were developed to
allow the estimation of the octanol/water parti-
tion coefficients for organic compounds on the
basis of numerical parameters assigned to the
various structural constituents. In the present
case, the only difference between the compounds
lies in their R groups, so the sum ofthe 1x factors
of the R groups alone was used to estimate the
relative differences in hydrophobicity of the di-
thiocarbamates used (Table 3).
Figure 1 shows a plot of the survival ratio
versus IXn. It is quite interesting that all ofthese
dithiocarbamates show some antidotal activity
Table 3. x parameters for dithiocarbamates studied.a
Compound R, R2 Es
I C2H5 C2H5 2.04
II CH3 CH3 1.12
III C2H40H C2H40H - 1.54
IV CH3 CH2COOH - 2.44
V CH3 C2H4OH - 0.21
VI CH2COOH CH2COOH - 3.72
VII C2H5 C2H40H + 0.25
VIII C3H8 C2H40H + 0.78
aThe values for the substituent constants ofthe individual
groups are those given by Hansch and Leo (6). Ivr for a
compound is simply the sum ofthe rc values given for each of
the R groups; thus for compound V, 1iT = wr(CH3) +
ir(CH2CH20H) = 0.56 + -0.77 = 0.21. The introduction ofa
negative charge leads to a contribution of -2.28 to 1wr.
under the conditions used. There is a decrease in
the antidotal action for the most hydrophobic of
the compounds, the diisopropyl derivative. The
fact that some of these compounds facilitate the
entry of cadmium into the brain is an obvious
disadvantage. Therelative amountofcadmiumin
the brain is plotted against In in Figure 2. This
amount appears to increase when En increases
above about +0.25. The relative amount of cad-
mium remaining in the kidney is also a parame-
ter that presumably should be low. The depen-
dence ofthis on XI is shown in Figure 3.
The net efficacy ofthese compounds should be
represented by a parameter which combines the
favorable andunfavorable aspects ofthebehavior
of these compounds. The construction of such a
parameter is somewhat arbitrary but, in general,
it should increase as the desirable actions are
more prominent and decrease as the adverse ef-
fects become more evident. The combination
which we selected to represent this overall anti-
dotal efficacy ofthese compounds is:
Efficacy = SR - (Rel. Br Cd/2) -
(Rel. Kid. Cd/2)
where SR is survival ratio, Rel. Br. Cd/2 is rela-
tive brain cadmium . 2 and Rel. Kid. Cd/2 =
relative kidney cadmium . 2.
This overall efficacy is plotted against In in
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FIGURE 4. Relative efficacy vs. Y1T.The relative efficacy used
here as the ordinate is defined as: survival rate - (relative
kidney cadmium)/2 - (relative brain cadmium)/2.
Figure 4. While there is some scatter in the plot,
it hints strongly that compounds in the central
portion ofthe Int range possess that combination
of properties which provide for an optimal effi-
cacy, using the definition ofefficacy given above.
The fact that there was a 2-hr interval between
the administration of cadmium and that of the
antidote is also ofpossible special significance. A
compound effective under such conditions is ap-
parently able to remove cadmium from binding
sites from which it cannot be easily removed by
EDTA or DTPA. Numerous studies have shown
that EDTA and DTPA lose at least part of their
antidotal efficacy unless given almost immedi-
ately after the cadmium (9-12). It has also been
demonstrated that this falloffin antidotal efficacy
occurs at a more rapid rate than that at which
metallothionein synthesis is induced in the liver
(13). The dithiocarbamates used in the present
study may be able to remove cadmium from those
sites which are responsible for the falloff in the
antidotal efficacy of EDTA type chelators. These
sites may well be intracellular ones to which
EDTA or DTPA do not have access (13).
The analysis of antidotal efficacy presented
here is quite different from the usual one which is
based solely on the relative values ofthe stability
constants of the various metal complexes in-
volved (14). The apparent reason for this is the
very high probability that these compounds can
chelate to cadmium which is intracellular in na-
ture, while the typical chelating agent of the
EDTA type or other highly ionized sort has an
extremely limited ability to penetrate the cell
membrane. It would appearpossible thenthat the
factors governing the relative efficacy of chelat-
ing agents which are to act intracellularly are
significantly more complex than those governing
chelating agents whose action is solely extracell-
ular.
Sodium diethyldithiocarbamate-and presum-
ably its less thoroughly studied analogs used
here-differs in some important ways from the
majority of the chelating agents which are used
therapeutically. Thedithiocarbamates aremetab-
olized quite rapidly to a variety of products in-
cluding the disulfuram derivatives, carbon disul-
fide and the parent amine among others (16,17).
The ability of this compound to gain entry into
cells can be inferred from its effectiveness as an
antidote for tetracarbonylnickel(O), Ni(CO)4
(18). This latter compound has a lowboilingpoint
and behaves much like a nonpolar organic com-
pound when administered to rats (19). The fact
(18) that sodium diethyldithiocarbamate is an
effective antagonist to nickel carbonyl when
given several hours after exposure to Ni(CO4)
indicates that its distribution in the human body
mimics, at least in part, that of Ni(CO)4. Its
behavior in the case ofcadmium-intoxicated ani-
mals is also consistent with an ability to get into
cells in which part of the cadmium has been
taken up. Because sodium diethyldithiocarba-
mate is charged, it may be that this transport
through the cell membrane is accomplished by
some ofits metabolic products which then revert
to the dithiocarbamate.
The data presented in Table 1 and the mode of
action proposed for these compounds suggest that
they might be effective even when the delay be-
tween administration ofthe cadmium and the anti-
dote is significantly greater than 2 hr. Gale and his
co-workers (1) have presented evidence showing
that diethyldithiocarbamate can have a very pro-
nounced antidotal action even when its admin-
istration is delayed as much as 6 hours. We carried
out analogous experiments on sodium di(hydroxy-
ethyl)dithiocarbamate, and these results, shown in
Table 2, indicate that this compound also exhibits
considerable antidotal activity when its admin-
istration is delayed by as much as 8 hr. When ani-
mals are given 10 mg CdCl2 2.5H20 intra-
peritoneally, and no antidote, none survive to the
endofthe 2-weekperiodused inthese experiments.
The analysis presented here has been used to
select compounds for testing in chronic cadmium
intoxication in mice. Results obtainedto date (15)
confirm the ability of dithiocarbamates such as
sodium di(hydroxyethyl)dithiocarbamate to mo-
bilize cadmium, even from aged deposits, without
increasing the concentration of cadmium in the
brain. Should these compounds prove to have no
untoward long-term effects, they may provide a
vehicle for the mobilization of cadmium in
chronic human cadmium intoxication. The use of
parameters related to the partition coefficient of
289290 JONES AND JONES
the chelating agent and its metal complexes as
developed here may also prove useful in other
cases where chelating agents are needed to mobi-
lize metals from intracellular sites. This type of
situation is found in patients with chronic metal
poisoning due to long-term environmental expo-
sure as well as those with iron-overload due to a
long series ofblood transfusions (20), hepatolenti-
cular degeneration with its accumulation of cop-
per (21) or in thallium intoxication, where in-
jested thallium replaces the potassium ion (22).
We wish to acknowledge, with thanks, the support provided
for this work by the National Institute of Environmental
Health Sciences via grant ES-02638-02.
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